NexGel Inc is on the Cruelty-Free Investing usage of animals list because they undertake pre-clinical studies on animals to examine the safety profile of their medications.
The company stated in the following report that they exploit animals for drug testing.
“We have conducted one animal and two human cadaver proof of concept studies with respect to NEXDrape. As a result of these studies, we believe NEXDrape will represent a gentle to the skin alternative to the current adhesive based standard of care and will provide a unique solution for patients with fragile or compromised skin.” (Page 5) Read the full document
NexGel, Inc. is provider of ultra-gentle, high-water-content hydrogels for healthcare and consumer applications. The Company is engaged in manufacturing high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery and cosmetics. It is specialized in custom gels by capitalizing on proprietary manufacturing technologies. The products it sells under its MedaGel brand primarily relate to over-the-counter (OTC) remedy solutions, such as blister and pain applications; while the products it sells under its LumaGel Beauty brand primarily relate to beauty and cosmetic solutions, such as wrinkle and skin cream applications.
Company Website: https://nexgel.com